| 000 | 01300 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513212630.0 | ||
| 264 | 0 | _c20000629 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a1084-9785 | ||
| 024 | 7 |
_a10.1089/cbr.1996.11.289 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNieken, J | |
| 245 | 0 | 0 |
_aOutpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update. _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cOct 1996 |
||
| 300 |
_a289-95 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutpatients |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aSleijfer, D T | |
| 700 | 1 | _aButer, J | |
| 700 | 1 | _ade Leij, L | |
| 700 | 1 | _aMulder, N H | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 11 _gno. 5 _gp. 289-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1996.11.289 _zAvailable from publisher's website |
| 999 |
_c10802606 _d10802606 |
||